Previously we have introduced a single cell system allowing long term culturing (1 week) of adult rat ventricular myocytes while maintaining their overall morphology, contractile behaviour and calcium-signalling. Here, we characterize the subcellular morphology of the myocytes, including the Golgi apparatus, endo-/sarcoplasmic reticulum (ER/SR), plasma membrane and mitochondria. Cells were isolated from adult rats following a standard enzymatic procedure. Organelles were labelled using targeted expression of fluorescent proteins, e.g. dsRed1 fused to the subunit VIII of human cytochrome C oxidase for mitochondria, YFP fused to a GPI-anchor for the plasma membrane, YFP fused to ts045G for the Golgi apparatus and dsRed2 fused to calreticulin for the ER/ SR. Complementing this we also applied fluorescent dyes; di-8-ANEPPS for the plasma membrane and MitoTracker Green for the mitochondria. 3-dimensional stacks of individual cells were acquired with a nipkow-disc based confocal microscope. Using both labelling approaches, the analysis of the plasma membrane illustrated a gradual loss of the t-tubules during culturing with cytosolic membrane fragments being present for extended time periods. Mitochondria, which are very prominent and densely packed in cardiac myocytes, underwent an apparent fusion of originally isolated mitochondria, possibly reflecting the loss of t-tubules. While the structure of the ER/SR remained unaltered, the Golgi apparatus underwent a significant redistribution during the culturing time from a wide cytosolic distribution to a perinuclear accumulation. We provide important evidence that cell morphology changes unavoidably occurring in adult cardiac myocytes during long term culture are highly reproducible and thus strongly support the application of such a single cell model in high-content screening applications. This work was funded by the Graduate School 1326, the SFB 530 and the KliFor 196. Current inotropic drug therapies used to boost cardiac muscle performance focus on elevating the amount of calcium that is mobilized for activation of the myofilaments. These calcium based therapies can provide short term benefits, but when administered long term can actually increase mortality due to calcium overload and the development of fatal arrhythmias. Calcium mobilization has also been the key target for current gene therapy strategies (i.e. SERCA2a over-expression, PLN knockdown, S100 protein expression) to treat the failing heart. Here we present a novel form of calcium independent positive inotropy by fast cardiac myosin motor gene transfer. We designed a recombinant adenovirus to express the full length human a-myosin heavy chain (a-MyHC, MYH6) gene in rabbit or human ventricular myocytes that endogenously express almost exclusively b-MyHC. Healthy or diseased adult cardiac myocytes were isolated by enzymatic digestion and maintained in primary culture for 48 hours. Highly efficient a-MyHC gene transfer was confirmed by fluorescent immunocytochemistry and Western blotting. In all cases contractility of single cardiac myocytes was measured 48 hours after gene transfer of a-MyHC by measuring sarcomere shortening and intracellular calcium transients. Sarcomere shortening was~35% greater in cardiac myocytes transduced with the a-MyHC adenovirus when a-MyHC made up~30% of the total myosin protein. Intracellular calcium transient amplitudes, however, were not affected by a-MyHC gene transfer. In permeabilized myocyte experiments we found that a-MyHC gene transfer did not affect myofilament calcium sensitivity, but did speed the kinetics of myosin cross bridge transitions from weakly-bound to strongly-bound states. We conclude that a-MyHC gene transfer offers a novel form of calcium independent positive inotropy for b-MyHC dominant adult ventricular myocytes. Waseda University, Tokyo, Japan. The basis of the Frank-Starling mechanism of the heart is the intrinsic ability of cardiac sarcomeres to produce greater active force in response to stretch (i.e., length-dependent activation). We have reported that troponin plays a key role in this phenomenon via on-off switching of the thin filament state, in concert with titin-based passive force (Terui et al., J Gen. Physiol. 131;275-283:2008). In the present study, we systematically investigated the role of thin filament cooperative activation in length-dependent activation using skinned porcine ventricular muscle at sarcomere lengths of 1.9 and 2.3 mm. MgADP (3 mM) increased Ca 2þ sensitivity of force and enhanced the speed of contraction, indicating enhanced cooperative activation. MgADP was found to attenuate length-dependent activation, with and without quasi-complete reconstitution of thin filaments with fast skeletal troponin (sTn; from rabbits). Conversely, inorganic phosphate (Pi, 20 mM) decreased Ca 2þ sensitivity of force and the speed of contraction, indicating reduced cooperative activation. Pi enhanced length-dependent activation, with and without sTn reconstitution. Qualitatively similar results were obtained with MgADP or Pi in rabbit fast skeletal muscle, with higher Ca 2þ sensitivity of force than in cardiac muscle. Linear regression analysis revealed that the speed of contraction, Ca 2þ sensitivity of force and length-dependent activation were strongly correlated in both cardiac and skeletal muscle. These results suggest that length-dependent activation is regulated via thin filament cooperative activation, such that the length-dependent increase in the fraction of cross-bridges is less in high cooperative activation states, coupled with a loss of recruitable cross-bridges.
1
University of Michigan, Ann Arbor, MI, USA, 2 University of Minnesota, Minneapolis, MN, USA. Current inotropic drug therapies used to boost cardiac muscle performance focus on elevating the amount of calcium that is mobilized for activation of the myofilaments. These calcium based therapies can provide short term benefits, but when administered long term can actually increase mortality due to calcium overload and the development of fatal arrhythmias. Calcium mobilization has also been the key target for current gene therapy strategies (i.e. SERCA2a over-expression, PLN knockdown, S100 protein expression) to treat the failing heart. Here we present a novel form of calcium independent positive inotropy by fast cardiac myosin motor gene transfer. We designed a recombinant adenovirus to express the full length human a-myosin heavy chain (a-MyHC, MYH6) gene in rabbit or human ventricular myocytes that endogenously express almost exclusively b-MyHC. Healthy or diseased adult cardiac myocytes were isolated by enzymatic digestion and maintained in primary culture for 48 hours. Highly efficient a-MyHC gene transfer was confirmed by fluorescent immunocytochemistry and Western blotting. In all cases contractility of single cardiac myocytes was measured 48 hours after gene transfer of a-MyHC by measuring sarcomere shortening and intracellular calcium transients. Sarcomere shortening was~35% greater in cardiac myocytes transduced with the a-MyHC adenovirus when a-MyHC made up~30% of the total myosin protein. Intracellular calcium transient amplitudes, however, were not affected by a-MyHC gene transfer. In permeabilized myocyte experiments we found that a-MyHC gene transfer did not affect myofilament calcium sensitivity, but did speed the kinetics of myosin cross bridge transitions from weakly-bound to strongly-bound states. We conclude that a-MyHC gene transfer offers a novel form of calcium independent positive inotropy for b-MyHC dominant adult ventricular myocytes. The basis of the Frank-Starling mechanism of the heart is the intrinsic ability of cardiac sarcomeres to produce greater active force in response to stretch (i.e., length-dependent activation). We have reported that troponin plays a key role in this phenomenon via on-off switching of the thin filament state, in concert with titin-based passive force (Terui et al., J Gen. Physiol. 131; 275-283:2008) . In the present study, we systematically investigated the role of thin filament cooperative activation in length-dependent activation using skinned porcine ventricular muscle at sarcomere lengths of 1.9 and 2.3 mm. MgADP (3 mM) increased Ca 2þ sensitivity of force and enhanced the speed of contraction, indicating enhanced cooperative activation. MgADP was found to attenuate length-dependent activation, with and without quasi-complete reconstitution of thin filaments with fast skeletal troponin (sTn; from rabbits). Conversely, inorganic phosphate (Pi, 20 mM) decreased Ca 2þ sensitivity of force and the speed of contraction, indicating reduced cooperative activation. Pi enhanced length-dependent activation, with and without sTn reconstitution. Qualitatively similar results were obtained with MgADP or Pi in rabbit fast skeletal muscle, with higher Ca 2þ sensitivity of force than in cardiac muscle. Linear regression analysis revealed that the speed of contraction, Ca 2þ sensitivity of force and length-dependent activation were strongly correlated in both cardiac and skeletal muscle. These results suggest that length-dependent activation is regulated via thin filament cooperative activation, such that the length-dependent increase in the fraction of cross-bridges is less in high cooperative activation states, coupled with a loss of recruitable cross-bridges. Introduction: Information on the force-length relation of intact myocytes from different regions of the heart is scarce. We therefore studied myocytes, isolated from apical and basal areas of guinea pig left and right ventricles (cell numbers: LV A 22, LV B 29, RV A 11, RV B 12). Methods: Force-length relations were measured by attaching carbon fibers to myocytes, allowing application of diastolic stretch while measuring passive and active force.
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1 Cells were kept at 3651 C and paced at 2 Hz. Recorded forces were normalized to cell crosssectional area and used to construct end-diastolic, end-systolic and active tension-length relations (EDTL, ESTL and ATL¼ESTL-EDTL; respectively). In addition, the ratio of the slopes of ESTL and EDTL was used as a cross-section independent factor to characterise the Frank-Starling Gain (FSG) 
